GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Weed Inc (OTCPK:BUDZ) » Definitions » Interest Coverage

Weed (BUDZ) Interest Coverage : 0 (At Loss) (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Weed Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Weed's Operating Income for the three months ended in Mar. 2024 was $-0.17 Mil. Weed's Interest Expense for the three months ended in Mar. 2024 was $-0.00 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Weed's Interest Coverage or its related term are showing as below:


BUDZ's Interest Coverage is not ranked *
in the Drug Manufacturers industry.
Industry Median: 12.56
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Weed Interest Coverage Historical Data

The historical data trend for Weed's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Weed Interest Coverage Chart

Weed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Weed Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - No Debt -

Competitive Comparison of Weed's Interest Coverage

For the Drug Manufacturers - Specialty & Generic subindustry, Weed's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Weed's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Weed's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Weed's Interest Coverage falls into.



Weed Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Weed's Interest Coverage for the fiscal year that ended in Dec. 2023 is calculated as

Here, for the fiscal year that ended in Dec. 2023, Weed's Interest Expense was $-0.05 Mil. Its Operating Income was $-0.77 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

Weed did not have earnings to cover the interest expense.

Weed's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Here, for the three months ended in Mar. 2024, Weed's Interest Expense was $-0.00 Mil. Its Operating Income was $-0.17 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

Weed did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Weed  (OTCPK:BUDZ) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Weed Interest Coverage Related Terms

Thank you for viewing the detailed overview of Weed's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Weed (BUDZ) Business Description

Traded in Other Exchanges
N/A
Address
4920 North Post Trail, Tucson, AZ, USA, 85750
Weed Inc is working on or planning for several different business opportunities in the cannabis and hemp field, including, but not limited to both indoor and outdoor grows, cultivations, and harvest for research, product development, processing, and manufacturing of both Pharma and non-Pharma products, services, therapeutics, and treatments on a global basis for both the Medical Cannabis and Hemp global market space.
Executives
Nicole M Breen director, 10 percent owner, officer: Secretary/Treasurer 4920 N. POST TRAIL, TUCSON AZ 85750
Elliot Kwestel director 5 AUERBACH LANE, LAWRENCE NY 11559
Lawrence G Dykers director 11924 N CENTAURUS PLACE, ORO VALLEY AZ 85737
Glynn A Burkhardt director, 10 percent owner, officer: Senior Vice President 3400 E. SPEEDWAY BLVD., SUITE 118-300, TUCSON AZ 85716
Roger Mccaslin director 11924 N. CENTAURUS PLACE, ORO VALLEY AZ 85737
Glenn E. Martin director, 10 percent owner, officer: President and Chairman of BOD 4920 N. POST TRAIL, TUCSON AZ 85750
Robert A Metz director, officer: Vice President 3400 E. SPEEDWAY BLVD., SUITE 118-300, TUCSON AZ 85716
Robert A Leitzman director, officer: CFO, CAO and V.P. 3400 E. SPEEDWAY BLVD., SUITE 118-300, TUCSON AZ 85716
Glynn A. Burkhardt director, 10 percent owner, officer: Senior V.P. 11924 N. CENTAURUS PLACE, ORO VALLEY AZ 85737
Donald J Steinberg director, officer: Former Officer and Director 3223 SUMAC ROAD, FALLBROOK CA 92028